Probiotic supplementation to mitigate berotralstat gastrointestinal side effects: a multicenter case series from the ITACA network

IntroductionBerotralstat, the first oral plasma kallikrein inhibitor approved for hereditary angioedema (HAE) prophylaxis, may be associated with gastrointestinal (GI) side effects, particularly during the first three months of therapy. Probiotics have been shown to reduce GI disturbances in several...

詳細記述

書誌詳細

主要な著者:	Antonio Gidaro, Maria Domenica Guarino, Francesco Arcoleo, Donatella Bignardi, Cristian D’Antonio, Luisa Brussino, Pietro Accardo, Stefania Nicola, Stefano Pucci, Miriam Cognigni, Valentina Popescu Janu, Chiara Cogliati, Emanuele Bizzi, Mauro Cancian
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2026-04-01
シリーズ:	Frontiers in Immunology
主題:	berotralstat gastrointestinal side effects hereditary angioedema ITACA long term prophylaxis microbiome
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1790199/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!